Philip Morris International Inc (PM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Philip Morris International Inc (PM) has a cash flow conversion efficiency ratio of 0.055x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-399.00 Million) by net assets ($-7.30 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Philip Morris International Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Philip Morris International Inc - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Philip Morris International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Philip Morris International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Philip Morris International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Merck & Company Inc
NYSE:MRK
|
0.085x |
|
Royal Bank of Canada
TO:RY
|
-0.106x |
|
Novartis AG
MX:NVSN
|
0.094x |
|
General Electric Company
SA:GEOO34
|
0.100x |
|
AstraZeneca PLC
NASDAQ:AZN
|
0.071x |
|
Novartis AG ADR
NYSE:NVS
|
0.094x |
|
AstraZeneca PLC
NYSE:AZN
|
0.071x |
|
GE Vernova LLC
NYSE:GEV
|
0.344x |
Annual Cash Flow Conversion Efficiency for Philip Morris International Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Philip Morris International Inc from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Philip Morris International Inc (PM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-8.03 Billion | $12.23 Billion | -1.524x | -23.11% |
| 2024-12-31 | $-9.87 Billion | $12.22 Billion | -1.238x | -27.03% |
| 2023-12-31 | $-9.45 Billion | $9.20 Billion | -0.974x | +43.08% |
| 2022-12-31 | $-6.31 Billion | $10.80 Billion | -1.712x | -17.41% |
| 2021-12-31 | $-8.21 Billion | $11.97 Billion | -1.458x | -57.97% |
| 2020-12-31 | $-10.63 Billion | $9.81 Billion | -0.923x | +12.20% |
| 2019-12-31 | $-9.60 Billion | $10.09 Billion | -1.051x | -19.10% |
| 2018-12-31 | $-10.74 Billion | $9.48 Billion | -0.883x | -1.31% |
| 2017-12-31 | $-10.23 Billion | $8.91 Billion | -0.871x | -17.56% |
| 2016-12-31 | $-10.90 Billion | $8.08 Billion | -0.741x | -8.12% |
| 2015-12-31 | $-11.48 Billion | $7.87 Billion | -0.685x | +0.79% |
| 2014-12-31 | $-11.20 Billion | $7.74 Billion | -0.691x | +57.24% |
| 2013-12-31 | $-6.27 Billion | $10.13 Billion | -1.615x | +68.23% |
| 2012-12-31 | $-1.85 Billion | $9.42 Billion | -5.084x | -185.13% |
| 2011-12-31 | $1.76 Billion | $10.53 Billion | 5.972x | +224.08% |
| 2010-12-31 | $5.12 Billion | $9.44 Billion | 1.843x | +43.63% |
| 2009-12-31 | $6.14 Billion | $7.88 Billion | 1.283x | +21.27% |
| 2008-12-31 | $7.50 Billion | $7.93 Billion | 1.058x | +191.54% |
| 2007-12-31 | $15.40 Billion | $5.59 Billion | 0.363x | -16.97% |
| 2006-12-31 | $14.27 Billion | $6.24 Billion | 0.437x | -12.66% |
| 2005-12-31 | $10.31 Billion | $5.16 Billion | 0.500x | +13.39% |
| 2003-12-31 | $10.49 Billion | $4.63 Billion | 0.441x | -- |
About Philip Morris International Inc
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.